Category Archives: MultiMax

Chemical Process Development Symposium at Novartis

Cambridge, Massachusetts is a unique place due to having one of the largest (per capita) and most impressive populations of scientists and engineers in the world.  Because of this, Cambridge is recognized as a global hub for biotechnology.  This makes the Boston area an attractive venue to organize a chemical process development gathering. Continue reading

Process Analytical Technology (PAT) & Laboratory Automation Developments in the Pharmaceutical & Chemical Industries

Dominique Hebrault will present the online seminar New Developments in the Use of PAT and Laboratory Automation from the Pharmaceutical and Chemical Industries on September 15.  Specific case studies that Dominique will discuss include: Continue reading

A Conversation with Danny Levin at Scientific Update’s January 2010 Organic Process R&D Meeting in San Diego


OPRD-Norac-Pharma-Danny-Levin-Dominique-Hebrault

Figure 1 - Summary of OPRD article by Danny Levin et al

I recently had a chance to meet with Danny Levin, President at Norac Pharma, during the 21st International Conference on Organic Process Research & Development (Scientific Update), January 2010, San Diego, CA.

After my presentation at the Organic Process Research & Development (OPRD) conference, Danny Levin described a paper he published a few years ago when he was head of research at NPIL Pharma Torcan (Org. Process Res. Dev., 2006, 10(6), pp 1296–1298). I had already used Danny Levin’s paper several times in my conference talks (figure 1) to illustrate the power of heat flow (Tr-Tj) at small scale, and Danny graciously provided some additional insight:

“I thought you might be interested in a publication of my own where I used METTLER TOLEDO MultiMax to good purpose in identifying and mitigating process scale up safety concerns during process development of a Horner Wadsworth Emmons reaction […]

The situation with the case study that I published was that we had been given a chemistry procedure that was believed by the originator to be safe and under control by virtue of slow addition of reagents. The MultiMax plot of (Tr-Tj) showed that this wasn’t the case – reagents were accumulating and the reaction and all the significant heat output occurred during warming for work-up!!!

It was the MultiMax data that quickly demonstrated the scale up hazard and allowed us to define a safely scaleable process. This critical aspect was not obvious from the presentation summary you kindly sent. You may wish to emphasize this point in future presentations to demonstrate the role of MultiMax in identifying and highlighting unsafe chemistry”.

Continue reading

Welcome to the Chemical Research, Development and Scale-up Blog for the Chemical and Bio-Pharmaceutical Industries

This Blog is designed to keep you informed of the latest information and news covering chemical research, development and scale-up for the chemical and bio-pharmaceutical industries.

Blog posts will include our latest application information and news in chemical research, development and scale-up.

Please subscribe to our RSS Feed to continue to get the latest information.

For more information:
About the Chemical Research, Development and Scale-up for the Chemical and Bio-pharmaceutical Industries Blog
About METTLER TOLEDO AutoChem